Upgrade to SI Premium - Free Trial

Haemonetics (HAE)

102.92 +0.07 (0.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Azenta names board member as interim CEO after Marotta resigns August 24, 2026 8:01 AM - StreetInsider AZENTA ANNOUNCES LEADERSHIP TRANSITION August 24, 2026 8:00 AM - PR NewsWire Haemonetics (HAE) PT Raised to $119 at Baird August 21, 2026 7:14 AM - StreetInsider Haemonetics signs non-exclusive supply deal with CSL Plasma August 18, 2026 6:06 AM - StreetInsider Form 8-K HAEMONETICS CORP For: Aug 18 August 18, 2026 6:05 AM - SEC Filing Form SCHEDULE 13G/A HAEMONETICS CORP Filed by: AQR CAPITAL MANAGEMENT LLC August 12, 2026 1:29 PM - SEC Filing Haemonetics (HAE) PT Raised to $86 at JPMorgan August 7, 2026 9:03 AM - StreetInsider Form S-8 HAEMONETICS CORP August 6, 2026 4:24 PM - SEC Filing Haemonetics (HAE) PT Raised to $96 at BTIG August 6, 2026 1:21 PM - StreetInsider Haemonetics (HAE) Tops Q1 EPS by 5c, Beats on Revenue August 6, 2026 6:13 AM - StreetInsider Form 10-Q HAEMONETICS CORP For: Jun 27 August 6, 2026 6:10 AM - SEC Filing Form 8-K HAEMONETICS CORP For: Aug 06 August 6, 2026 6:09 AM - SEC Filing Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website August 6, 2026 6:00 AM - PR NewsWire Haemonetics study backs vascular closure device in large-bore procedures August 3, 2026 4:16 PM - StreetInsider New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths August 3, 2026 4:15 PM - PR NewsWire Form 4 HAEMONETICS CORP For: Jul 24 Filed by: Madaus Martin D July 28, 2026 5:04 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: Zane Ellen M July 28, 2026 5:03 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: Pomeroy Claire July 28, 2026 5:01 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: KROLL MARK W July 28, 2026 4:58 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: Johnson Lloyd Emerson July 28, 2026 4:57 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: COYLE MICHAEL J July 28, 2026 4:54 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: Bryant Diane M July 28, 2026 4:52 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jul 24 Filed by: ABERNATHY ROBERT E July 28, 2026 4:50 PM - SEC Filing Form 3 HAEMONETICS CORP For: Jul 24 Filed by: Madaus Martin D July 28, 2026 4:47 PM - SEC Filing Form 8-K HAEMONETICS CORP For: Jul 24 July 28, 2026 4:28 PM - SEC Filing Haemonetics adds Martin Madaus to its board of directors July 28, 2026 4:15 PM - StreetInsider Martin Madaus Elected to Haemonetics Board of Directors July 28, 2026 4:15 PM - PR NewsWire Haemonetics (HAE) PT Raised to $90 at Mizuho July 15, 2026 6:39 AM - StreetInsider U.S. MedTech stocks: Q2 earnings preview July 12, 2026 10:00 AM - StreetInsider Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 July 8, 2026 4:05 PM - PR NewsWire Citi Adds Four Names to Catalyst Call List July 8, 2026 5:18 AM - StreetInsider BTIG Reiterates Buy Rating on Haemonetics (HAE) June 26, 2026 5:45 AM - StreetInsider Haemonetics (HAE) PT Raised to $85 at Mizuho June 15, 2026 6:38 AM - StreetInsider Form ARS HAEMONETICS CORP For: Mar 28 June 9, 2026 4:23 PM - SEC Filing Form DEFA14A HAEMONETICS CORP June 9, 2026 4:21 PM - SEC Filing Form DEF 14A HAEMONETICS CORP For: Mar 28 June 9, 2026 4:18 PM - SEC Filing Full Article List